GGrantIndex
Sort

172,184 grants matching inflammation

Biomechanics of Leukocytes and Molecular Imaging Agents

$1,042,268
Michael Brandeau Lawrence · University Of Virginia · R01 · FY2010 · EB

Magnetic Resonance Studies Of Cells, Organs And Animals

$1,042,232
Richard Spencer · Aging · Z01 · FY2007 · AG

HIV Exposed Uninfected Infant Cohort Study

$1,042,202
Donald M Thea · Boston University Medical Campus · R01 · FY2021 · HD

Pulmonary valved conduit xenograft with regeneration potential

$1,042,014
Ajay Houde · Annoviant, Inc · R44 · FY2022 · HL

Development of a Molecular Assay to Diagnose Malignant Pleural Effusions

$1,041,709
Mark A Nelson · Precision Epigenomics, Inc. · R44 · FY2025 · CA

Uterine Leiomyomas

$1,041,576
Donna D. Baird · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES

Candidate selection of a LPAR1 antagonist for therapeutic application in NASH

$1,041,548
Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2024 · DK

Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer

$1,041,509
Charles S Fuchs · Yale University · R01 · FY2017 · CA

Uterine Leiomyomas

$1,041,427
Donna D. Baird · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES

Telomere Diseases and Other Constitutional and Acquired Genetic Disorders of Hematopoiesis

$1,041,424
Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL

Core B - Developmental

$1,041,383
Ira B Wilson · Miriam Hospital · P30 · FY2019 · AI

Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation

$1,041,302
Angus W Thomson · University Of Pittsburgh At Pittsburgh · U19 · FY2022 · AI

Biology of the Lung: A Multidisciplinary Program

$1,041,209
Boston University Medical Campus · T32 · FY2003 · HL

Immune checkpoint inhibitors and accelerated coronary atherosclerosis

$1,041,129
Tomas G Neilan · Massachusetts General Hospital · R01 · FY2022 · HL

Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)

$1,041,032
Mark Andrew Espeland · Wake Forest University Health Sciences · R01 · FY2021 · AG

Cytokines and T Cell Development

$1,041,000
Scott Durum · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

The Centrosome as a master controller of platelet production.

$1,040,760
Joseph E Italiano · Boston Children'S Hospital · R35 · FY2024 · HL

Imaging Core

$1,040,591
Duy Tran · National Institute Of Dental & Craniofacial Research · ZIC · FY2022 · DE

Functional characterization of viral-bacterial-human interactions during antimicrobial and inflammatory perturbations across different lifespans

$1,040,503
Gautam Dantas · Washington University · U01 · FY2025 · AT

Molecular Prediction of Myeloma Initiation Molecular Prediction of Myeloma Initiation

$1,040,400
Irene M. Ghobrial · Dana-Farber Cancer Inst · R35 · FY2025 · CA

Clinical Research on Nonalcoholic Fatty Liver Disease

$1,040,313
Joel Edward Lavine · Columbia University Health Sciences · U01 · FY2014 · DK

Aminergic Function in Aging and Alzheimers Disease

$1,040,183
University Of South Florida · P01 · FY2004 · AG

Clinical Outcomes in Rehabilitated Burn Children

$1,039,810
David N Herndon · University Of Texas Med Br Galveston · P50 · FY2009 · GM

5/9 Predictors and Mechanisms of Conversion to Psychosis

$1,039,764
Diana O. Perkins · Univ Of North Carolina Chapel Hill · U01 · FY2016 · MH

1/2 Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC)

$1,039,725
Gregory Jay Cole · North Carolina Central University · U54 · FY2022 · AA